Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol for Prevention of Chemotherapy-Induced Cardiomyopathy
NCT00806390Phase 4Terminated
- Sponsor
- University of Maryland, Baltimore
- Start
- Jul 2008
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metoprolol in cardiomyopathy (2 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Left Ventricular Ejection Fraction. Started Jul 2008; status: terminated.
02
Drugs
metoprolol
03
Conditions
cardiomyopathy
Beyond the preview
Go deeper on NCT00806390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00806390.